Literature DB >> 17314113

Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients.

Christophe Bauters1, Pierre V Ennezat, Olivier Tricot, Bénédicte Lauwerier, Robert Lallemant, Hassan Saadouni, Philippe Quandalle, Olivier Jaboureck, Nicolas Lamblin, Thierry Le Tourneau.   

Abstract

AIMS: Stress hyperglycaemia (SH) is associated with adverse outcome in patients with acute myocardial infarction (MI) but the mechanisms underlying this association are unknown. Our hypothesis was that SH on admission for acute MI may be associated with left ventricular (LV) remodelling. METHODS AND
RESULTS: We analysed LV remodelling in 162 non-diabetic patients with anterior MI. SH was defined as a glycaemia on admission >or=7 mmol/L. Systematic echocardiographic follow-up was performed at 3 months and 1 year after MI. The changes in end-diastolic volume (EDV) and end-systolic volume (ESV) from baseline to 1 year were 11.4 +/- 16.5 and 6.4 +/- 12.4 ml/m(2), respectively, in patients with SH vs. 1.9 +/- 11.1 and 0.2 +/- 8.5 ml/m(2), respectively, in patients without SH (both P < 0.0001). When LV remodelling was defined as a >20% increase in EDV, it was observed in 46% patients in the SH group vs. 19% patients in the no SH group (P = 0.0008). By multivariable analysis, baseline wall motion score index (P = 0.001) and SH (P = 0.009) were independently associated with changes in EDV. SH was an independent predictor of LV remodelling [adjusted OR: 3.22 (1.31-7.94)].
CONCLUSION: SH is a major and independent predictor of LV remodelling after anterior MI in non-diabetic patients.

Entities:  

Mesh:

Year:  2007        PMID: 17314113     DOI: 10.1093/eurheartj/ehl546

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

1.  Admission glucose and left ventricular systolic function in non-diabetic patients with acute myocardial infarction.

Authors:  Joanna Gierach; Marcin Gierach; Iwona Świątkiewicz; Marek Woźnicki; Grzegorz Grześk; Adam Sukiennik; Marek Koziñski; Jacek Kubica
Journal:  Heart Vessels       Date:  2014-12-25       Impact factor: 2.037

2.  Predictive Value of Fasting Blood Glucose for Microvascular Obstruction in Nondiabetic Patients with ST-Segment Elevation Myocardial Infarction after Primary Percutaneous Coronary Intervention.

Authors:  Han Wu; Ran Li; Kun Wang; Dan Mu; Jian-Zhou Chen; Xuan Wei; Xue Bao; Zhong-Hai Wei; Jun Xie; Biao Xu
Journal:  Cardiol Res Pract       Date:  2020-09-26       Impact factor: 1.866

3.  Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography.

Authors:  Yaron Arbel; Margalit Zlotnik; Amir Halkin; Ofer Havakuk; Shlomo Berliner; Itzhak Herz; Itay Rabinovich; Gad Keren; Shmuel Bazan; Ariel Finkelstein; Shmuel Banai
Journal:  Clin Res Cardiol       Date:  2013-11-24       Impact factor: 5.460

Review 4.  Stress Induced Hyperglycemia in the Context of Acute Coronary Syndrome: Definitions, Interventions, and Underlying Mechanisms.

Authors:  Mingmin Li; Guo Chen; Yingqing Feng; Xuyu He
Journal:  Front Cardiovasc Med       Date:  2021-05-12

5.  Augmented glycaemic gap is a marker for an increased risk of post-infarct left ventricular systolic dysfunction.

Authors:  Yong Zhu; Kesen Liu; Shuai Meng; Ruofei Jia; Xuan Lei; Maolin Chen; Kaiyuan Zou; Huagang Zhu; Zening Jin
Journal:  Cardiovasc Diabetol       Date:  2020-07-04       Impact factor: 9.951

6.  The stress hyperglycaemia ratio is associated with left ventricular remodelling after first acute ST-segment elevation myocardial infarction.

Authors:  Shuai Meng; Yong Zhu; Kesen Liu; Ruofei Jia; Jing Nan; Maolin Chen; Xuan Lei; Kaiyuan Zou; Zening Jin
Journal:  BMC Cardiovasc Disord       Date:  2021-02-04       Impact factor: 2.298

7.  Association of stress induced hyperglycemia with angiographic findings and clinical outcomes in patients with ST-elevation myocardial infarction.

Authors:  Nikolaos Stalikas; Andreas S Papazoglou; Efstratios Karagiannidis; Eleftherios Panteris; Dimitrios Moysidis; Stylianos Daios; Vasileios Anastasiou; Vasiliki Patsiou; Triantafyllia Koletsa; George Sofidis; Georgios Sianos; George Giannakoulas
Journal:  Cardiovasc Diabetol       Date:  2022-07-26       Impact factor: 8.949

8.  Lack of recognition and documentation of stress hyperglycemia is a disruptor of optimal continuity of care.

Authors:  Eric D Moyer; Erik B Lehman; Matthew D Bolton; Jennifer Goldstein; Ariana R Pichardo-Lowden
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

9.  An Overview of Concentrated Insulin Products.

Authors:  Nathan A Painter; Evan Sisson
Journal:  Diabetes Spectr       Date:  2016-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.